Michèle Grappin

1.5k total citations
33 papers, 1.0k citations indexed

About

Michèle Grappin is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Michèle Grappin has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Emergency Medicine. Recurrent topics in Michèle Grappin's work include HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (10 papers) and HIV Research and Treatment (9 papers). Michèle Grappin is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (10 papers) and HIV Research and Treatment (9 papers). Michèle Grappin collaborates with scholars based in France, United States and Canada. Michèle Grappin's co-authors include Michel Duong, H. Portier, P. Chavanet, Lionel Piroth, Marielle Buisson, Gilles Peytavin, Anne Waldner, Jean Michel Petit, Patrick Hillon and Catherine Quantin and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Michèle Grappin

33 papers receiving 988 citations

Peers

Countries citing papers authored by Michèle Grappin

Since Specialization

Citations

This map shows the geographic impact of Michèle Grappin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Grappin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Grappin more than expected).

Fields of papers citing papers by Michèle Grappin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Grappin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Grappin. The network helps show where Michèle Grappin may publish in the future.

Co-authorship network of co-authors of Michèle Grappin

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Grappin. A scholar is included among the top collaborators of Michèle Grappin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Grappin. Michèle Grappin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ocular Syphilis and HIV Infection 2009 ·Sexually Transmitted Diseases ·Damien Biotti, Samuel Bidot, Sophie Mahy, Marielle Buisson, Michel Duong, Michèle Grappin, Catherine Creuzot‐Garcher, P. Chavanet, Lionel Piroth	18
2	Treatment of chronic hepatitis C in HIV-infected patients: From clinical trials to field practice 2008 ·Scandinavian Journal of Infectious Diseases ·Lionel Piroth, Benoît Martha, Anne Minello, Michèle Grappin, P. Chavanet	6
3	Concentration of Circulating Oxidized LDL in HIV-Infected Patients Treated with Antiretroviral Agents: Relation to HIV-Related Lipodystrophy 2006 ·HIV Clinical Trials ·Michel Duong, Jean Michel Petit, Benoît Martha, F. Galland, Lionel Piroth, (unknown), Michèle Grappin, Marielle Buisson, Laurence Duvillard, P. Chavanet, H. Portier	35
4	Les abcès pyogènes secondaires du psoas : à propos de six cas et revue de la littérature 2006 ·La Revue de Médecine Interne ·Sylvain Audia, Benoît Martha, Michèle Grappin, Michel Duong, M. Buisson, J.F. Couaillier, B. Lorcerie, P. Chavanet, H. Portier, Lionel Piroth	16
5	Usefulness of Therapeutic Drug Monitoring of Antiretrovirals in Routine Clinical Practice 2004 ·HIV Clinical Trials ·Michel Duong, (unknown), Gilles Peytavin, Lionel Piroth, Marie Froidure, Michèle Grappin, Marielle Buisson, Évelyne Kohli, P. Chavanet, H. Portier	14
6	Clinical, Immunological and Virological Evolution in Patients with CD4 T-Cell Count above 500/mm3: Is there a Benefit to Treat with Highly Active Antiretroviral Therapy (HAART)? 2004 ·European Journal of Epidemiology ·Lionel Piroth, Christine Binquet, Marielle Buisson, Évelyne Kohli, Michel Duong, Michèle Grappin, Michał Abrahamowicz, Catherine Quantin, H. Portier, P. Chavanet	5
7	Acute Liver Enzyme Elevations in HIV-1-Infected Patients 2003 ·HIV Clinical Trials ·(unknown), Christine Binquet, Catherine Sgro, Marie Froidure, Michel Duong, Marielle Buisson, Michèle Grappin, Catherine Quantin, H. Portier, P. Chavanet, Lionel Piroth	17
8	[Struggle against infectious risk in splenectomized subjects. Certitude and questions]. 2003 ·PubMed ·H. Portier, Michèle Grappin	1
9	Nouvelle stratégie de prise en charge des angines en France 2003 ·Bulletin de l Académie Nationale de Médecine ·H. Portier, Michèle Grappin, P. Chavanet	4
10	The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients 2002 ·Journal of Hepatology ·Lionel Piroth, Christine Binquet, (unknown), Anne Minello, (unknown), Jean‐Baptiste Bour, Marielle Buisson, Michel Duong, Michèle Grappin, H. Portier, P. Chavanet	89
11	Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected Patients 2002 ·Clinical Infectious Diseases ·Geneviève Chêne, (unknown), Laurent Cotte, Jean-Marie Lang, Philippe Morlat, Corinne Rancinan, (unknown), Valérie Journot, (unknown), B Jarrousse, Michèle Grappin, G. Lepeu, Jean‐Michel Molina, (unknown)	84
12	Exercise Stress Testing for Detection of Silent Myocardial Ischemia in Human Immunodeficiency Virus—Infected Patients Receiving Antiretroviral Therapy 2002 ·Clinical Infectious Diseases ·Michel Duong, Yves Cottin, Lionel Piroth, (unknown), (unknown), (unknown), Michèle Grappin, M. Buisson, Marianne Zeller, P. Chavanet, Jean‐Eric Wolf, H. Portier	29
13	Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral Therapy 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michel Duong, Jean Michel Petit, Lionel Piroth, Michèle Grappin, Marielle Buisson, P. Chavanet, Patrick Hillon, H. Portier	98
14	Coronary heart disease associated with the use of human immunodeficiency virus (HTV)‐1 protease inhibitors: Report of four cases and review 2001 ·Clinical Cardiology ·Michel Duong, Marielle Buisson, Yves Cottin, Lionel Piroth, Isabelle L’Huillier, Michèle Grappin, P. Chavanet, (unknown), H. Portier	23
15	Evaluation of the Patient Medication Adherence Questionnaire As a Tool for Self-Reported Adherence Assessment in HIV-Infected Patients on Antiretroviral Regimens 2001 ·HIV Clinical Trials ·Michel Duong, Lionel Piroth, Michèle Grappin, (unknown), Gilles Peytavin, Marielle Buisson, P. Chavanet, H. Portier	87
16	Value of Patient Self‐Report and Plasma Human Immunodeficiency Virus Protease Inhibitor Level as Markers of Adherence to Antiretroviral Therapy: Relationship to Virologic Response 2001 ·Clinical Infectious Diseases ·Michel Duong, Lionel Piroth, Gilles Peytavin, (unknown), Évelyne Kohli, Michèle Grappin, Marielle Buisson, P. Chavanet, H. Portier	75
17	Therapeutic Trials in HIV Infection: Which Benefits for Which Patients? 2001 ·HIV Clinical Trials ·Lionel Piroth, (unknown), Michèle Grappin, Michel Duong, Marielle Buisson, H. Portier, P. Chavanet	2
18	HIV-1 Protease Inhibitors Induce an Increase of Triglyceride Level in HIV-Infected Men Without Modification of Insulin Sensitivity: A Longitudinal Study 2000 ·Hormone and Metabolic Research ·Jean‐Michel Petit, Michel Duong, Laurence Duvillard, Lionel Piroth, Michèle Grappin, Bruno Vergès, P. Chavanet, (unknown), H. Portier	39
19	Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? 1998 ·AIDS ·Lionel Piroth, Michel Duong, Catherine Quantin, Michał Abrahamowicz, (unknown), Serge Aho, Michèle Grappin, Marielle Buisson, Anne Waldner, H. Portier, P. Chavanet	159
20	Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro–in vivo correlation in HIV-infected patients 1994 ·AIDS ·(unknown), José Luis López‐Pérez, Michèle Grappin, Alain Bonnin, Michel Duong, Anne Waldner, (unknown), P. Camerlynck, H. Portier	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact